Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r9data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

MYNERVA AG

History from 2 Jun 2025

UID
CHE-198.869.269
Legal form
AG
Canton
ZH
Founded
2 Jun 2025
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 123k
31k61k92k123k15 Jul 2026 · CHF 118k6 Oct 2026 · CHF 123k
  • shares
  • Vorzugsaktien

Record

  1. Company formed

    Founded 2 Jun 2025

    SHAB HR01-1006348352 ↗
  2. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    100’000 → 118’318.56
    Shares
    10’000’000 → 11’831’856
    New shares, % of post-step shares
    15.5% (1’831’856 new)
    Share classes
    10’000’000 × CHF 0.01 · 1’831’856 × CHF 0.01 Vorzugsaktien
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.95 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006707044 ↗
  3. Capital band adopted

    SHAB HR02-1006707044 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    118’318.56 → 122’743.33
    Shares
    11’831’856 → 12’274’333
    New shares, % of post-step shares
    3.6% (442’477 new)
    Share classes
    10’000’000 × CHF 0.01 · 2’274’333 × CHF 0.01 Vorzugsaktien
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006774630 ↗
  5. Capital band adopted

    SHAB HR02-1006774630 ↗

Published by 8 Oct 2026